-
Our Quest for the Holy Grail in Coronary Artery Disease. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-10 Armin Arbab-Zadeh
-
Imaging and Precision Medicine: The End of the Road for "Lumpers?" JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-01 Thomas H Marwick,Y Chandrashekhar
-
Revisiting Diagnostic Criteria for Hypertrophic Cardiomyopathy in Hypertensive and Nonhypertensive Patients. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-01 Yong-Huai Wang,Chun-Yan Ma
-
Harnessing SGLT2 Inhibitors: A New Frontier in Cardiac Remodeling for Nondiabetic Heart Failure. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-01 Cindy M Martin
-
Quantitative Myocardial Perfusion Imaging: A Case of "More Than Meets the Eye?" JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-01 Kim A Connelly,Yin Ge
-
Coronary Artery Calcium Distribution and Cardiovascular Risk: MESA. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-27 Tara Shrout Allen,Mikaila Reyes,Jonathan M Kermanshahchi,Julie O Denenberg,Joseph Yeboah,Matthew A Allison,Michael H Criqui,Harpreet S Bhatia
-
Long-Term Treatment With Mavacamten and Improved Left Atrial Strain in Obstructive Hypertrophic Cardiomyopathy. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-26 Hyun-Jung Lee,Geu-Ru Hong
-
The Complex Relationship Between Risk Factor Exposure and Coronary Epicardial as Well as Microvascular Disease. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-23 Joanne D Schuijf,João A C Lima
-
Leveraging a Vision Transformer Model to Improve Diagnostic Accuracy of Cardiac Amyloidosis With Cardiac Magnetic Resonance. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-22 Joshua Cockrum,Makiya Nakashima,Carl Ammoury,Diane Rizkallah,Joseph Mauch,David Lopez,David Wolinksy,Tae Hyun Hwang,Samir Kapadia,Lars G Svensson,Richard Grimm,Mazen Hanna,W H Wilson Tang,Christopher Nguyen,David Chen,Deborah Kwon
BACKGROUND Cardiac magnetic resonance (CMR) imaging is an important diagnostic tool for diagnosis of cardiac amyloidosis (CA). However, discrimination of CA from other etiologies of myocardial disease can be challenging. OBJECTIVES The aim of this study was to develop and rigorously validate a deep learning (DL) algorithm to aid in the discrimination of CA using cine and late gadolinium enhancement
-
Mechanism and Impact of Left Atrial Dyssynchrony on Long-Term Clinical Outcome During Cardiac Resynchronization Therapy JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-20 Lars-Egil R. Hammersboen MD, Marie Stugaard MD PhD, Alexis Puvrez MD, Camilla K. Larsen MD PhD, Espen W. Remme MSc PhD, Erik Kongsgård MD PhD, Jürgen Duchenne MSc PhD, Elena Galli MD PhD, Faraz H. Khan MD, Ole Jakob Sletten MD, Martin Penicka MD PhD, Erwan Donal MD PhD, Jens-Uwe Voigt MD PhD, Otto A. Smiseth MD PhD, John M. Aalen MD PhD
Left bundle branch block (LBBB) causes left atrial (LA) dyssynchrony. It is unknown if LA dyssynchrony impacts long-term prognosis.
-
-
-
Cancer and the Heart: What Do We Really Know About Imaging? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-04 Paaladinesh Thavendiranathan MD SM, Y. Chandrashekhar MD
-
Improving Precision and Refining Risk Prediction of CTRCD With Cardiovascular CT JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-04 Purvi J. Parwani MBBS MPH, Juan Lopez-Mattei MD
-
Echocardiographic Evaluation of Chronic Aortic Regurgitation: Comparison With Cardiac Magnetic Resonance and Implications for Guideline Recommendations. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-30 Rowa Attar,Maan Malahfji,Clara Angulo,Duc T Nguyen,Edward A Graviss,Dipan J Shah,William A Zoghbi
BACKGROUND Guidelines for echocardiographic evaluation of aortic regurgitation (AR) have not been validated against an independent quantitative standard. OBJECTIVES The aim of this study was to evaluate the accuracy of the ASE (American Society of Echocardiography) AR guidelines against cardiac magnetic resonance (CMR) and to develop simplified approaches for detection of significant AR. METHODS Patients
-
Coronary Plaque Radiomic Phenotypes Predict Fatal or Nonfatal Myocardial Infarction: Analysis of the SCOT-HEART Trial JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-30 Márton Kolossváry MD PhD, Andrew Lin MBBS BMedSc PhD, Jacek Kwiecinski MD PhD, Sebastien Cadet MS, Piotr J. Slomka PhD, David E. Newby MD PhD, Marc R. Dweck MD PhD, Michelle C. Williams MD PhD, Damini Dey PhD
Coronary computed tomography (CT) angiography–derived attenuation-based plaque burden assessments can identify patients at risk of myocardial infarction.
-
Echocardiographic Markers of Early Left Ventricular Dysfunction in Asymptomatic Aortic Regurgitation: Is It Time to Change the Guidelines? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-29 Vidhu Anand,Hector I Michelena,Christopher G Scott,Alexander T Lee,Vera H Rigolin,Sorin V Pislaru,Garvan C Kane,Juan A Crestanello,Patricia A Pellikka
BACKGROUND The ideal timing for surgery in asymptomatic chronic aortic regurgitation (AR) remains unclear. New thresholds for left ventricular ejection fraction (LVEF), left ventricular (LV) indexed end-systolic volume (iESV), and global longitudinal strain (GLS) have been associated with mortality in these patients. These represent markers of early LV dysfunction. OBJECTIVES The authors sought to
-
Calcium Scoring and Plaque Density: Room for Improvement. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-26 Harpreet S Bhatia
-
Parsing the Shades of Gray of Myocardial Fibrosis in Aortic Stenosis. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-25 Tom Kai Ming Wang,Tiffany Dong
-
Cholesterol, Atherosclerotic, and Inflammatory Risks Among Patients With Statin Therapy JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-23 Neng Dai MD, Yiqing Hu MS, Xianglin Tang MD, WeiFeng Guo MD, Zhenyang Guo MS, Fan Zhou MS, Longjiang Zhang MD, Pranav Prakash Edavi MS, Hao Lu MD, Juying Qian MD, Junbo Ge MD
-
Looking Beyond Stenosis: The Emerging Role of Cardiac CT in Unveiling Microvascular Dysfunction JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-23 Abdul Rahman Ihdayhid MBBS PhD, Nestor Gahungu MD MPhil
-
-
-
Calcification vs Inflammation: The Modern Toolkit for Cardiovascular Risk Assessment JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-07 Charalambos Antoniades MD PhD, Kenneth Chan MBBS
-
Evolving Approaches for Diagnostic Testing in Suspected Coronary Artery Disease JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-07 Leslee J. Shaw PhD, Y.S. Chandrashekhar MD DM
-
Impact of Bariatric Surgery on Coronary Microvascular Function: When Lower Weight Means Better Flow! JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-02 Paul Poirier MD PhD
-
Stress CMR Perfusion Imaging in the Medicare-Eligible Population: Insights From the SPINS Study. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-01 Yin Ge,Panagiotis Antiochos,Benedikt Bernhard,Bobak Heydari,Kevin Steel,Scott Bingham,J Ronald Mikolich,Andrew E Arai,W Patricia Bandettini,Amit R Patel,Sujata M Shanbhag,Afshin Farzaneh-Far,John F Heitner,Chetan Shenoy,Steve W Leung,Jorge A Gonzalez,Dipan J Shah,Subha V Raman,Victor A Ferrari,Jeanette Schulz-Menger,Matthias Stuber,Orlando P Simonetti,Raymond Y Kwong
BACKGROUND Patients aged ≥65 years account for a disproportionately large portion of cardiovascular (CV) events and pose a challenge for noninvasive detection of coronary artery disease. OBJECTIVES This study sought to determine the prognostic value of stress cardiac magnetic resonance (CMR) in a Medicare-eligible group of patients in a multicenter setting in the United States. METHODS From a multicenter
-
Right Ventricular Systolic Strain Reference Ranges Across Contemporary Vendor-Neutral Echocardiography Software in Healthy Patients. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-24 Elio Haroun,Ankit Agrawal,Joseph El Dahdah,Tiffany Dong,Aro Daniela Arockiam,Muhammad Majid,Sharmeen Sorathia,Richard A Grimm,L Leonardo Rodriguez,Zoran B Popovic,Brian P Griffin,Tom Kai Ming Wang
-
Myocardial Blood Flow Quantification Using Stress Cardiac Magnetic Resonance Improves Detection of Coronary Artery Disease JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-18 Shuo Wang MD, Paul Kim MD, Haonan Wang PhD, Ming-Yen Ng BMBS, Andrew E. Arai MD, Amita Singh MD, Saima Mushtaq MD, Tsun Hei Sin BSc, Yuko Tada MD PhD, Elizabeth Hillier MD PhD, Ruyun Jin MD MCR, Christian Østergaard Mariager PhD, Michael Salerno MD PhD, Gianluca Pontone MD, Javier Urmeneta Ulloa PhD, Ibrahim M. Saeed MD, Hena Patel MD, Victor Goh MBBS, Simon Madsen MD, Won Yong Kim MD, Mayil Singram
Myocardial blood flow (MBF) and myocardial perfusion reserve (MPR) using stress cardiovascular magnetic resonance (CMR) have been shown to identify epicardial coronary artery disease. However, comparative analysis between quantitative perfusion and conventional qualitative assessment (QA) remains limited.
-
Vascular Remodeling in Coronary Microvascular Dysfunction JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Carlos Collet MD PhD, Koshiro Sakai MD PhD, Takuya Mizukami MD PhD, Hirofumi Ohashi MD PhD, Frederic Bouisset MD, Serena Caglioni MD, Lieven van Hoe MD, Emanuele Gallinoro MD PhD, Dario Tino Bertolone MD, Sofie Pardaens MSc PhD, Sofie Brouwers MD PhD, Tatyana Storozhenko MD, Ruiko Seki MD, Daniel Munhoz MD PhD, Atomu Tajima MD, Dimitri Buytaert MsC, Marc Vanderheyden MD, Eric Wyffels MD, Jozef Bartunek
Approximately one-half of the patients with angina and nonobstructive coronary artery disease (ANOCA) have evidence of coronary microvascular dysfunction (CMD).
-
Fibro-Calcific Imaging: A Step Towards a More Comprehensive Approach to Aortic Valve Pathophysiology? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Stephanie L. Sellers MSc PhD, David Meier MD
-
Polygenic Risk and the Progression of High-Risk Coronary Plaque JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Nicholas A. Marston MD MPH
-
Head-to-Head Comparison of Near-Infrared Spectroscopy–Intravascular Ultrasound and Coronary Computed Tomography Angiography in Assessing Atheroma Characteristics JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Anantharaman Ramasamy MBChB PhD, Francesca Pugliese MD PhD, Ibrahim Halil Tanboga MD PhD, Pieter Kitslaar MSc, Jouke Dijkstra PhD, Anthony Mathur MD PhD, Ryo Torii PhD, James C. Moon MD, Andreas Baumbach PhD MD, Christos V. Bourantas MD PhD
-
Predictors for Vulnerable Plaque in Functionally Significant Lesions JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Seokhun Yang MD, Doyeon Hwang MD, Koshiro Sakai MD PhD, Takuya Mizukami MD PhD, Jonathon Leipsic MD, Marta Belmonte MD, Jeroen Sonck MD PhD, Bjarne L. Nørgaard MD PhD, Hiromasa Otake MD PhD, Brian Ko MD PhD, Michael Maeng MD PhD, Jesper Møller Jensen MD PhD, Dimitri Buytaert MSc, Daniel Munhoz MD PhD, Daniele Andreini MD PhD, Hirofumi Ohashi MD PhD, Toshiro Shinke MD PhD, Charles A. Taylor PhD, Emanuele
Vulnerable plaque presents prognostic implications in addition to functional significance. The aim of this study was to identify relevant features of vulnerable plaque in functionally significant lesions. In this multicenter, prospective study conducted across 5 countries, including patients who had invasive fractional flow reserve (FFR) ≤0.80, a total of 95 patients with available pullback pressure
-
Diffuse Interstitial Fibrosis of the Myocardium Predicts Outcome in Moderate and Asymptomatic Severe Aortic Stenosis. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-10 Hyun-Jung Lee,Anvesha Singh,Jaehyun Lim,Neil Craig,Rong Bing,Lionel Tastet,Jun-Bean Park,Hyung-Kwan Kim,Yong-Jin Kim,Marie-Annick Clavel,Bernhard L Gerber,Gerry P McCann,Marc R Dweck,Phillipe Pibarot,Seung-Pyo Lee
BACKGROUND Patients with moderate or asymptomatic severe aortic stenosis (AS) are at risk of cardiovascular events. OBJECTIVES The authors investigated the utility of cardiac magnetic resonance (CMR) to identify drivers of outcome in patients with moderate or asymptomatic severe AS. METHODS A prospective, international, multicenter cohort (n = 457) of patients with moderate (aortic valve area [AVA]:
-
High-Gradient Aortic Stenosis With Valve Area >1.0 cm2: The "Forgotten" Discordant Hemodynamic Phenotype. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-05 Saki Ito,Jae K Oh,Hector I Michelena,Alexander C Egbe,Heidi M Connolly,Patricia A Pellikka,Vuyisile T Nkomo,Bradley R Lewis,William R Miranda
BACKGROUND Clinical features and outcomes in severe aortic stenosis (AS) have been described according to the hemodynamic phenotypes. OBJECTIVES The aim of this study was to investigate the clinical features and prognosis of patients with high-gradient (HG) AS with aortic valve area (AVA) >1.0 cm2. METHODS A total of 3,209 patients were identified according to AVA (cm2), peak velocity (m/s), systolic
-
Treatment Strategy of Atrial Functional Mitral Regurgitation: Consideration of the Mechanistic Subtypes. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Nobuyuki Kagiyama
-
Precision Medicine in Ischemic Heart Disease Through Point-of-Care Myocardial Contrast Echocardiography JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Weiting Huang MBBS, Matteo Morello MD, Bethany A. Gholson RCS ACS, Jonathan R. Lindner MD
-
Clinical Utility of LA Indices in Chronic Severe Aortic Regurgitation: A Comes Before V JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Kazuaki Negishi MD PhD MSc, Koya Ozawa MD PhD
-
Relationship Between Calcified Plaque Burden, Vascular Inflammation, and Plaque Vulnerability in Patients With Coronary Atherosclerosis JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Daichi Fujimoto MD PhD, Daisuke Kinoshita MD PhD, Keishi Suzuki MD PhD, Takayuki Niida MD PhD, Haruhito Yuki MD, Iris McNulty RN, Hang Lee PhD, Hiromasa Otake MD PhD, Junya Shite MD PhD, Maros Ferencik MD PhD MCR, Damini Dey PhD, Tsunekazu Kakuta MD PhD, Ik-Kyung Jang MD PhD
Coronary artery calcification is an integral part of atherosclerosis. It has been suggested that early coronary artery calcification is associated with active inflammation, and advanced calcification forms as inflammation subsides. Inflammation is also an important factor in plaque vulnerability. However, the relationship between coronary artery calcium burden, vascular inflammation, and plaque vulnerability
-
NSTEMI: To Image or Not to Image Prior to Coronary Angiography? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-03 Barbara Lawson MD, W. Gregory Hundley MD
-
What Is New With Understanding the Left Atrium and What It Can Tell Us JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-03 Thomas H. Marwick MBBS PhD MPH, Y. Chandrashekhar MD
-
Harnessing PET Imaging for Prognostic Precision in Cardiac Sarcoidosis JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-03 Panithaya Chareonthaitawee MD, John P. Bois MD
-
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-02 Milind Y. Desai MD MBA, Yuichiro Okushi MD, Kathy Wolski MPH, Jeffrey B. Geske MD, Anjali Owens MD, Sara Saberi MD MS, Andrew Wang MD, Paul C. Cremer MD MS, Mark Sherrid MD, Neal K. Lakdawala MD, Albree Tower-Rader MD, David Fermin MD, Srihari S. Naidu MD, Kathy L. Lampl MD, Amy J. Sehnert MD, Steven E. Nissen MD, Zoran B. Popovic MD PhD, VALOR-HCM Investigators, M. Desai, J. Geske, M. Sherrid, A.T
In severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM), the VALOR-HCM (A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Who Are Eligible for Septal Reduction Therapy) trial showed that mavacamten reduced the eligibility for septal reduction therapy with sustained improvement in left ventricular outflow tract gradients. Mavacamten
-
Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-31 Ana Devesa,Valentin Fuster,Inés García-Lunar,Belén Oliva,Ana García-Alvarez,Andrea Moreno-Arciniegas,Ravi Vazirani,Cristina Pérez-Herreras,Pablo Marina,Héctor Bueno,Leticia Fernández-Friera,Antonio Fernández-Ortiz,Javier Sanchez-Gonzalez,Borja Ibanez
BACKGROUND In patients with ischemic heart disease, coronary microvascular dysfunction is associated with cardiovascular risk factors and poor prognosis; however, data from healthy individuals are scarce. OBJECTIVES The purpose of this study was to assess the impact of cardiovascular risk factors and subclinical atherosclerosis on coronary microvascular function in middle-aged asymptomatic individuals
-
CTA-Derived Pericoronary Fat Attenuation Index Predicts Allograft Rejection and Cardiovascular Events in Heart Transplant Recipients. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-31 Angelo Sansonetti,Marta Belmonte,Marco Masetti,Luca Bergamaschi,Pasquale Paolisso,Laura Borgese,Francesco Angeli,Matteo Armillotta,Riet Dierckx,Sofie Verstreken,Nicola Gaibazzi,Domenico Tuttolomondo,Chiara Baldovini,Emanuele Barbato,Paola Rucci,Joseph Bartunek,Luciano Potena,Marc Vanderheyden,Carmine Pizzi
-
Diagnosing Myocarditis Using Cardiac Magnetic Resonance Imaging: Let’s Avoid Getting Burned JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-28 Chetan Shenoy MBBS MS, Parag H. Bawaskar MD DM
-
Three’s a Crowd: Use of Single vs Multiple Echocardiographic Core Laboratories JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-28 Judy Hung MD
-
Pulmonary Hypertension in Mitral Regurgitation: Silent, But Deadly JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-28 Paul C. Cremer MD MS, Vinay Guduguntla MD
-
Medium-Term Outcomes of Hospitalized COVID-19 Patients With Myocardial Injury: Cautiously Optimistic JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-28 Mahesh K. Vidula MD, Yuchi Han MD MMSc
-
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-28 Hunain Shiwani BMBS, Jessica Artico MD, James C. Moon MD, Miroslawa Gorecka MB, Gerry P. McCann MD, Giles Roditi MD, Andrew Morrow MBChB, Kenneth Mangion PhD, Elena Lukaschuk MSc, Mayooran Shanmuganathan MBBS, Christopher A. Miller PhD, Amedeo Chiribiri PhD, Mohammed Alzahir MBBS, Sara Ramirez MD, Andrew Lin MBBS, Peter P. Swoboda PhD, Adam K. McDiarmid PhD, Robert Sykes MBChB, Trisha Singh MBBS, Chiara
Hospitalized COVID-19 patients with troponin elevation have a higher prevalence of cardiac abnormalities than control individuals. However, the progression and impact of myocardial injury on COVID-19 survivors remain unclear.
-
Prevalence of Abnormal Atrial and Ventricular Mechanics and Its Reversibility in Patients With Atrial Fibrillation JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-28 Koki Nakanishi MD, Masao Daimon MD, Katsuhito Fujiu MD, Kentaro Iwama MD, Kazutoshi Hirose MD, Yuriko Yoshida MD, Yasuhiro Mukai MD, Hikari Seki MD, Yuko Yamamoto MD, Megumi Hirokawa MD, Tomoko Nakao MD, Tsukasa Oshima MD, Takumi Matsubara MD, Yu Shimizu MD, Gaku Oguri MD, Toshiya Kojima MD, Eriko Hasumi MD, Hiroyuki Morita MD, Makoto Kurano MD, Issei Komuro MD
-
Geographic Proximity to Cardiac Positron Emission Tomography Facilities Across the United States JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-28 Ahmed Sayed MBBS, Mouaz Al-Mallah MD
-
Myocardial Strain Imaging: Theory, Current Practice, and the Future. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-26 Otto A Smiseth,Oliver Rider,Marta Cvijic,Ladislav Valkovič,Espen W Remme,Jens-Uwe Voigt
Myocardial strain imaging by echocardiography or cardiac magnetic resonance (CMR) is a powerful method to diagnose cardiac disease. Strain imaging provides measures of myocardial shortening, thickening, and lengthening and can be applied to any cardiac chamber. Left ventricular (LV) global longitudinal strain by speckle-tracking echocardiography is the most widely used clinical strain parameter. Several
-
Academic Profile and Gender Representation of Advanced Cardiac Imaging Fellowship Program Directors in the United States. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-25 Vivek Bhat,Ashish Kumar,Ankur Kalra,Nandan Anavekar,Lauren A Baldassarre,Roosha Parikh,Purvi Parwani
-
Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-25 Yuanqi Yong,Julian Giovannucci,Sow Neng Pang,Wei Hong,Donghee Han,Daniel S Berman,Damini Dey,Stephen J Nicholls,Nitesh Nerlekar,Andrew Lin
BACKGROUND There is increasing evidence that coronary artery calcium (CAC) density is inversely associated with plaque vulnerability and atherosclerotic cardiovascular disease risk. OBJECTIVES A systematic review and meta-analysis were performed to examine the predictive value of CAC density for future cardiovascular events in asymptomatic individuals undergoing noncontrast CAC scoring computed tomography
-
Beyond the PROSPECT Trial: Markers of Mechanical Dyssynchrony to Improve Patient Selection for CRT JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-21 Alexis Puvrez MD, Oana Mirea MD PhD, Stella Marchetta MD, Bert Vandenberk MD PhD, Gábor Vörös MD PhD, Erwan Donal MD PhD, Nicholas Cauwenberghs PhD, Lennert Minten MD, Laurine Wouters MSc, Ward Heggermont MD PhD, Martin Penicka MD PhD, Ahmed S. Youssef MD, Jürgen Duchenne PhD, Jens-Uwe Voigt MD PhD
-
Unlocking Virtual Physiology Guided PCI: Point-of-Care CT-FFR Performance JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-21 Mariusz Kruk MD PhD, Marcin Demkow MD PhD, Jan Henzel MD PhD, Mariusz Dębski MD PhD, Piotr Rudziński MD PhD, Jakub Czarnecki, Marek Wiśniewski MD, Adam Witkowski MD PhD, Cezary Kępka MD PhD
-
Why Do Coronaries Spasm?: Getting to Grips With Atherosclerosis as a Substrate. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-21 Thabo Mahendiran,Bernard De Bruyne
-
A Home for the Orphan?: Isolated Tricuspid Regurgitation as Part of HFpEF JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-08-21 Wojciech Kosmala MD PhD